Influence Factors and Cognitive Characteristics in Unipolar and Bipolar Depression:Based on the THINC-it Tool
Based on the THINC-it Tool to Explore the Characteristics and Related Factors of Cognitive Impairment in the Acute Stage of Unipolar and Bipolar Depression
1 other identifier
observational
120
1 country
1
Brief Summary
Cognitive impairment is the core symptom of unipolar and bipolar depression, which seriously affects the prognosis of the disease and the rehabilitation of social function. There is no unified conclusion in the field and severity of cognitive impairment, and the cause of cognitive impairment is unknown, which may be related to many factors. In this study,the THINC-it tool was used to study the characteristics of cognitive impairment in unipolar and bipolar depression by longitudinal follow-up, which provides a theoretical basis for the differential diagnosis of unipolar and bipolar depression. Early identification and intervention of risk factors can improve the prognosis of the disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 15, 2021
CompletedFirst Submitted
Initial submission to the registry
September 13, 2021
CompletedFirst Posted
Study publicly available on registry
September 22, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2023
CompletedSeptember 14, 2022
September 1, 2021
1.5 years
September 13, 2021
September 9, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
the THINC-it Tool
The composite THINC-it tool score is the integrated total score of results from performance on five sub-component cognitive tests of the THINC-it tool.
up to 12 week
Secondary Outcomes (3)
HAMD-17
up to 12 week
HAM-A
up to 12 week
Pittsburgh Sleep Quality Index,PSQI
up to 12 week
Study Arms (3)
unipolar depression group
In accordance with the diagnostic criteria of ICD-10 Unipolar depressive disorder, outpatients or inpatients in the Department of mood Disorders, Mental Health Center of Pudong New area.
bipolar depression group
In accordance with the diagnostic criteria of ICD-10 Bipolar depression , outpatients or inpatients in the Department of mood Disorders, Mental Health Center of Pudong New area.
healthy control group
Any mental disorder that does not meet the diagnosis of ICD-10, and the society recruits healthy controls who match the sex, age and education level of the patients in the case-group.
Eligibility Criteria
According to the diagnostic criteria of ICD-10 Unipolar and bipolar depressive disorder, 40 patients with Major depressive disorder, 40 patients with bipolar depression and 40 healthy controls matched with the sex, age and education level of the patients in the case group served as healthy controls.
You may qualify if:
- Case group:
- 、Participants in psychiatric outpatients and inpatients are able and willing to provide informed consent.
- \. The participants were male or female aged between 18 and 60, with junior high school education or above.
- \. According to ICD-10 criteria, participants were diagnosed with Unipolar and bipolar depressive disorder.
- \. The total score of Young's Mania scale ((YMRS)) of the participants was less than 5 and HAMD-17 was greater than17.
- \. Subjects received stable mood stabilizers at least two weeks before the study visit, such as SSRIs antidepressants.
- \. The combination or use of supportive psychotherapy is allowed.
- Control group:
- it did not meet any of the diagnostic criteria in ICD-10 in the past or at present.
- years old, junior high school education or above. 3.Have sufficient audio-visual skills to complete the necessary examinations of the study.
- Willing to participate in this study, and the informed consent form was signed by the subjects.
You may not qualify if:
- Current alcohol and / or substance use disorders.
- Any drugs that may affect cognitive function, such as psychotropic stimulants, corticosteroids, and receptor blockers.
- Benzodiazepines were used within 12 hours and alcohol consumption within 8 hours before using the THINC-it tool.
- The patients have some serious physical conditions.
- The patients received electroconvulsive therapy ((ECT)) in the past 6 months.
- They are serious negative suicidal concepts and behaviors.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shanghai Mental Health Center IRB
Shanghai, Shanghai Municipality, 200030, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jun Chen, M.D., Ph.D
Shanghai Mental Health Center
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 13, 2021
First Posted
September 22, 2021
Study Start
May 15, 2021
Primary Completion
October 30, 2022
Study Completion
June 30, 2023
Last Updated
September 14, 2022
Record last verified: 2021-09